Jain Global LLC Exelixis, Inc. Transaction History
Jain Global LLC
- $11.9 Billion
- Q2 2025
A detailed history of Jain Global LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Jain Global LLC holds 69,989 shares of EXEL stock, worth $2.86 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
69,989Holding current value
$2.86 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
703Shares Held
264MCall Options Held
1.41MPut Options Held
1.55M-
Black Rock Inc. New York, NY33.5MShares$1.37 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.12 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$654 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$645 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$464 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...